Huntington National Bank’s PDL BioPharma, Inc. PDLI Stock Holding History

Huntington National Bank’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-80	Closed	–	–	2390
2018 Q4	$0	Buy	+80	New	+$220	﹤0.01%	2444
2018 Q2	–	Sell	-1,000	Closed	-$3K	–	1702
2018 Q1	$3K	Hold	1,000	–	–	﹤0.01%	1500
2017 Q4	$3K	Hold	1,000	–	–	﹤0.01%	1553
2017 Q3	$3K	Hold	1,000	–	–	﹤0.01%	1544
2017 Q2	$2K	Buy	+1,000	New	+$2.3K	﹤0.01%	1487
2015 Q3	–	Sell	-12,143	Closed	-$78K	–	1890
2015 Q2	$78K	Buy	+12,143	New	+$81.3K	﹤0.01%	989
2014 Q4	–	Sell	-41,300	Closed	-$309K	–	1844
2014 Q3	$309K	Sell	41,300 -12,700	-24%	-$118K	0.01%	811
2014 Q2	$523K	Hold	54,000	–	–	0.01%	697
2014 Q1	$449K	Buy	+54,000	New	+$463K	0.01%	819

Other funds holding PDLI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Huntington National Bank's PDLI Position: Q1 2019 in Review

Huntington National Bank sold out of PDL BioPharma, Inc. (PDLI) in Q1 2019, closing a stake of 80 shares.

Huntington National Bank first reported a position in PDLI in Q1 2014 and held it in 9 quarters. The position peaked at $523K in Q2 2014. 157 funds tracked by Wall St. Rank hold PDLI as of Q1 2019.

Huntington National Bank reported no remaining PDL BioPharma, Inc. position as of Q1 2019 after selling out during the quarter.
Huntington National Bank sold 80 PDL BioPharma, Inc. shares in Q1 2019.
Huntington National Bank first reported a position in PDL BioPharma, Inc. in Q1 2014 and held it in 9 quarters.
Huntington National Bank's PDL BioPharma, Inc. position peaked at $523K in Q2 2014.
157 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2019.

Based on Huntington National Bank's 13F filing for Q1 2019, filed 9 Apr 2019.